| Model Number |
305U225 |
| Medical Device Problem Code |
Device Stenosis (4066)
|
| Health Effect - Clinical Code |
Aortic Valve Stenosis (1717)
|
| Date of Event |
07/09/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that 1 year and 9 months post implant of this 25mm aortic bioprosthetic valve it experienced a valve performance issue and valve stenosis.A redo aortic valve replacement with a mechanical valve was planned.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
B2, b5 and imf (annex f) codes were updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received reported that on (b)(6) 2025, the patient successfully had a 26mm transcatheter valve-in-valve replacement.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|